Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

Share Price is delayed by 15 minutes
Get Live Data
520.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 20.00 (3.922%)
Market Cap: £85.31m
ANP Live PriceLast checked at - London Stock Exchange

Intraday Anpario Share Chart

Director/PDMR Shareholding

7 Jun 2021 15:58

RNS Number : 0767B
Anpario PLC
07 June 2021
 

 

Anpario plc("Anpario" or the "Company")

Director/PDMR Shareholding

Anpario announces that it was notified on 4 June 2021 by Peter Lawrence, Non-Executive Chairman, that on 4 June 2021 The Peter Lawrence And Family Charitable Trust sold 11,450 ordinary shares of 23p each in the Company ("Ordinary Shares") at a price of 610p each. Following the disposal, Peter Lawrence and his family have no remaining interest in the issued share capital of the Company.

Enquiries:

 

 

 

 

 

Anpario plc

 

 

Richard Edwards, Chief Executive Officer

+44 (0)7776 417 129

 

Karen Prior, Group Finance Director

+44 (0)1909 537 380

 

 

 

 

Peel Hunt LLP (NOMAD)

+44 (0)207 418 8900

 

Adrian Trimmings

 

 

Andrew Clark

 

 

Will Bell

 

 

 

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and their Closely Associated Persons

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Peter Lawrence

2

Reason for the notification

a)

Position/status

 

Non-Executive Chairman

b)

Initial notification/Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Anpario plc

b)

LEI

213800BZHUIUCH3MCC06

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code 

Sale of ordinary shares of 23 pence each in the Company ("Ordinary Shares")

 

ISIN GB00B3NWT178

 

 

b)

Nature of the transaction

 

Sale of Ordinary Shares

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

610p

11,450

 

d)

Aggregated information

 

Price(s)

Volume(s)

610p

11,450

 

e)

Date of the transaction

 

4 June 2021

f)

Place of the transaction

 

 

London Stock Exchange (XLON), AIM

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKZGGVDNNGMZM
Date   Source Headline
16th Dec 20247:00 amRNSLaunch of SAYE Scheme
29th Nov 20247:00 amRNSTotal Voting Rights
30th Sep 20247:00 amRNSAcquisition of Bio-Vet Inc.
13th Sep 20247:00 amRNSNotice of Investor Presentation
11th Sep 20247:00 amRNSInterim results
14th Aug 202411:22 amRNSDirector/PDMR Shareholding
18th Jul 20247:00 amRNSBlock listing Interim Review
25th Jun 20242:34 pmRNSResult of AGM
25th Jun 20247:00 amRNSAGM Statement
12th Jun 20244:11 pmRNSHolding(s) in Company
24th May 202410:04 amRNSPosting of Annual Report and Notice of AGM
21st Mar 202411:37 amRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSAward of Options and Director/PDMR Shareholding
24th Jan 20247:00 amRNSFull year trading statement
17th Jan 20247:00 amRNSBlock listing Interim Review
5th Oct 20239:23 amRNSDirector Disclosure
13th Sep 20237:00 amRNSHalf-year Report
25th Aug 20235:10 pmRNSBlock listing Interim Review
1st Aug 20237:00 amRNSDirectorate Change
10th Jul 20232:14 pmRNSHolding(s) in Company
7th Jul 20232:34 pmRNSHolding(s) in Company
29th Jun 20233:57 pmRNSResult of AGM
29th Jun 20237:00 amRNSAGM Statement
23rd Jun 20237:00 amRNSResult of Tender Offer
19th Jun 20232:48 pmRNSGM Statement
15th Jun 20237:00 amRNSShareholder Tour
7th Jun 20234:09 pmRNSReplacement - Tender Offer
6th Jun 20237:00 amRNSPosting of Annual Report and Notice of AGM
2nd Jun 20237:00 amRNSTender Offer
23rd May 20237:00 amRNSChange of Adviser
19th May 20234:40 pmRNSDirector Disclosures
19th May 20233:35 pmRNSTotal Voting Rights
5th May 20237:00 amRNSDirectorate Change
21st Apr 20237:00 amRNSAnpario receives King’s Award for Enterprise
11th Apr 20237:00 amRNSDirector/PDMR Shareholding
31st Mar 20231:13 pmRNSHolding(s) in Company
28th Mar 20237:00 amRNSDirector/PDMR Shareholding
22nd Mar 20237:00 amRNSFinal Results
3rd Feb 20237:00 amRNSDirector/PDMR Shareholding
24th Jan 202312:56 pmRNSBlock listing Interim Review
9th Jan 20237:00 amRNSFull Year Trading Statement
16th Dec 20227:00 amRNSAnpario receives ISO 14001 Certification
4th Nov 202212:52 pmRNSTotal Voting Rights
19th Oct 20227:00 amRNSDirector/PDMR Shareholding - Replacement
18th Oct 20227:00 amRNSDirector/PDMR Shareholding
6th Oct 20227:00 amRNSESG Initiatives
3rd Oct 20222:32 pmRNSDirector/PDMR Shareholding
14th Sep 20227:00 amRNSHalf-year Report
5th Sep 202212:38 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.